Cholera Toxin B Subunit: An Efficient Transmucosal Carrier-Delivery System for Induction of Peripheral Immunological Tolerance

Oral administration of antigens, including allergens and autoantigens, may be an efficient way to prevent diseases associated with untoward immune responses to self- and non-self-antigens. However, this approach has met with limitations because it usually requires repeated administrations of large d...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 1994-11, Vol.91 (23), p.10795-10799
Main Authors: Sun, Jia-Bin, Holmgren, Jan, Czerkinsky, Cecil
Format: Article
Language:English
Subjects:
Animals
Antibodies
Antigens
Antigens - administration & dosage
Biology
Cholera
Cholera Toxin - chemistry
Cholera Toxin - immunology
Dosage
Dose-Response Relationship, Immunologic
Erythrocytes
Female
gamma-Globulins - immunology
Hypersensitivity, Delayed - immunology
Immune Tolerance
Immunity (Disease)
Lymphocyte Activation
Medical research
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Oral administration
Reactivity
Self tolerance
Structure-Activity Relationship
Swelling
Vibrio cholerae
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oral administration of antigens, including allergens and autoantigens, may be an efficient way to prevent diseases associated with untoward immune responses to self- and non-self-antigens. However, this approach has met with limitations because it usually requires repeated administrations of large doses of antigen and is less efficient in an already immune host, and the effect is of short duration. We report that a single oral administration of minute amounts of particulate or soluble antigen coupled to the B subunit of cholera toxin (CTB) can markedly suppress systemic immune responses in naive and in systemically immune animals. Both early (2-4 hr) and late (24-48 hr) delayed type-hypersensitivity reactivities were strongly suppressed after feeding a single dose of CTB-conjugated antigen. Serum antibody responses were also decreased, although moderately, after oral administration of CTB-conjugated antigen. This strategy of tolerance induction, based on oral administration of small amounts of antigens conjugated to a mucosa-binding molecule, may find broad applications for preventing or abrogating untoward immune responses.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.91.23.10795